|
1
|
Sallusto F: Heterogeneity of Human CD4(+)
T Cells Against Microbes. Annu Rev Immunol. 34:317–334.
2016.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Blum JS, Wearsch PA and Cresswell P:
Pathways of antigen processing. Annu Rev Immunol. 31:443–473.
2013.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Duhen T, Duhen R, Lanzavecchia A, Sallusto
F and Campbell DJ: Functionally distinct subsets of human FOXP3+
Treg cells that phenotypically mirror effector Th cells. Blood.
119:4430–4440. 2012.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Luckheeram RV, Zhou R, Verma AD and Xia B:
CD4+T cells: Differentiation and functions. Clin Dev Immunol.
2012(925135)2012.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Mahnke YD, Beddall MH and Roederer M:
OMIP-017: Human CD4(+) helper T-cell subsets including follicular
helper cells. Cytometry A. 83:439–440. 2013.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Kanamori M, Nakatsukasa H, Okada M, Lu Q
and Yoshimura A: Induced Regulatory T Cells: Their Development,
Stability, and Applications. Trends Immunol. 37:803–811.
2016.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Mandapathil M, Hilldorfer B, Szczepanski
MJ, Czystowska M, Szajnik M, Ren J, Lang S, Jackson EK, Gorelik E
and Whiteside TL: Generation and accumulation of immunosuppressive
adenosine by human CD4+CD25highFOXP3+ regulatory T cells. J Biol
Chem. 285:7176–7186. 2010.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Borsellino G, Kleinewietfeld M, Di Mitri
D, Sternjak A, Diamantini A, Giometto R, Höpner S, Centonze D,
Bernardi G, Dell'Acqua ML, et al: Expression of ectonucleotidase
CD39 by Foxp3+ Treg cells: Hydrolysis of extracellular ATP and
immune suppression. Blood. 110:1225–1232. 2007.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Deaglio S, Dwyer KM, Gao W, Friedman D,
Usheva A, Erat A, Chen JF, Enjyoji K, Linden J, Oukka M, et al:
Adenosine generation catalyzed by CD39 and CD73 expressed on
regulatory T cells mediates immune suppression. J Exp Med.
204:1257–1265. 2007.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Longhi MS, Moss A, Jiang ZG and Robson SC:
Purinergic signaling during intestinal inflammation. J Mol Med
(Berl). 95:915–925. 2017.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Seddiki N, Cook L, Hsu DC, Phetsouphanh C,
Brown K, Xu Y, Kerr SJ, Cooper DA, Munier CM, Pett S, et al: Human
antigen-specific CD4(+) CD25(+) CD134(+) CD39(+) T cells are
enriched for regulatory T cells and comprise a substantial
proportion of recall responses. Eur J Immunol. 44:1644–1661.
2014.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Phetsouphanh C, Xu Y, Amin J, Seddiki N,
Procopio F, Sekaly RP, Zaunders JJ and Kelleher AD:
Characterization of transcription factor phenotypes within
antigen-specific CD4+ T cells using qualitative multiplex
single-cell RT-PCR. PLoS One. 8(e74946)2013.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Korkmaz B, Moreau T and Gauthier F:
Neutrophil elastase, proteinase 3 and cathepsin G: Physicochemical
properties, activity and physiopathological functions. Biochimie.
90:227–242. 2008.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Hof P, Mayr I, Huber R, Korzus E, Potempa
J, Travis J, Powers JC and Bode W: The 1.8 A crystal structure of
human cathepsin G in complex with Suc-Val-Pro-PheP-(OPh)2: A
Janus-faced proteinase with two opposite specificities. EMBO J.
15:5481–5491. 1996.PubMed/NCBI
|
|
15
|
Powers JC, Tanaka T, Harper JW, Minematsu
Y, Barker L, Lincoln D, Crumley KV, Fraki JE, Schechter NM, Lazarus
GG, et al: Mammalian chymotrypsin-like enzymes. Comparative
reactivities of rat mast cell proteases, human and dog skin
chymases, and human cathepsin G with peptide 4-nitroanilide
substrates and with peptide chloromethyl ketone and sulfonyl
fluoride inhibitors. Biochemistry. 24:2048–2058. 1985.PubMed/NCBI
|
|
16
|
Korkmaz B, Horwitz MS, Jenne DE and
Gauthier F: Neutrophil elastase, proteinase 3, and cathepsin G as
therapeutic targets in human diseases. Pharmacol Rev. 62:726–759.
2010.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Eipper S, Steiner R, Lesner A, Sienczyk M,
Palesch D, Halatsch ME, Zaczynska E, Heim C, Hartmann MD, Zimecki
M, et al: Lactoferrin Is an Allosteric Enhancer of the Proteolytic
Activity of Cathepsin G. PLoS One. 11(e0151509)2016.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Bangalore N, Travis J, Onunka VC, Pohl J
and Shafer WM: Identification of the primary antimicrobial domains
in human neutrophil cathepsin G. J Biol Chem. 265:13584–13588.
1990.PubMed/NCBI
|
|
19
|
Brinkmann V, Reichard U, Goosmann C,
Fauler B, Uhlemann Y, Weiss DS, Weinrauch Y and Zychlinsky A:
Neutrophil extracellular traps kill bacteria. Science.
303:1532–1535. 2004.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Thomas MP, Whangbo J, McCrossan G, Deutsch
AJ, Martinod K, Walch M and Lieberman J: Leukocyte protease binding
to nucleic acids promotes nuclear localization and cleavage of
nucleic acid binding proteins. J Immunol. 192:5390–5397.
2014.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Luster AD: Chemokines - chemotactic
cytokines that mediate inflammation. N Engl J Med. 338:436–445.
1998.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Owen CA, Campbell MA, Sannes PL, Boukedes
SS and Campbell EJ: Cell surface-bound elastase and cathepsin G on
human neutrophils: A novel, non-oxidative mechanism by which
neutrophils focus and preserve catalytic activity of serine
proteinases. J Cell Biol. 131:775–789. 1995.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Delgado MB, Clark-Lewis I, Loetscher P,
Langen H, Thelen M, Baggiolini M and Wolf M: Rapid inactivation of
stromal cell-derived factor-1 by cathepsin G associated with
lymphocytes. Eur J Immunol. 31:699–707. 2001.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Selak MA: Cathepsin G and thrombin:
Evidence for two different platelet receptors. Biochem J.
297:269–275. 1994.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Penczek A, Sienczyk M, Wirtz CR and
Burster T: Cell surface cathepsin G activity differs between human
natural killer cell subsets. Immunol Lett. 179:80–84.
2016.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Blue ML, Daley JF, Levine H and Schlossman
SF: Coexpression of T4 and T8 on peripheral blood T cells
demonstrated by two-color fluorescence flow cytometry. J Immunol.
134:2281–2286. 1985.PubMed/NCBI
|
|
27
|
Ortolani C, Forti E, Radin E, Cibin R and
Cossarizza A: Cytofluorimetric identification of two populations of
double positive (CD4+,CD8+) T lymphocytes in human peripheral
blood. Biochem Biophys Res Commun. 191:601–609. 1993.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Nascimbeni M, Shin EC, Chiriboga L,
Kleiner DE and Rehermann B: Peripheral CD4(+)CD8(+) T cells are
differentiated effector memory cells with antiviral functions.
Blood. 104:478–486. 2004.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Bonomo A, Kehn PJ and Shevach EM:
Premature escape of double-positive thymocytes to the periphery of
young mice. Possible role in autoimmunity. J Immunol.
152:1509–1514. 1994.PubMed/NCBI
|
|
30
|
Munschauer FE, Stewart C, Jacobs L, Kaba
S, Ghorishi Z, Greenberg SJ and Cookfair D: Circulating CD3+ CD4+
CD8+ T lymphocytes in multiple sclerosis. J Clin Immunol.
13:113–118. 1993.PubMed/NCBI
|
|
31
|
Mizuki M, Tagawa S, Machii T, Shibano M,
Tatsumi E, Tsubaki K, Tako H, Yokohama A, Satou S, Nojima J, et al:
Phenotypical heterogeneity of CD4+CD8+ double-positive chronic T
lymphoid leukemia. Leukemia. 12:499–504. 1998.PubMed/NCBI
|
|
32
|
Yamazaki T and Aoki Y: Cathepsin G binds
to human lymphocytes. J Leukoc Biol. 61:73–79. 1997.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Dwyer KM, Deaglio S, Gao W, Friedman D,
Strom TB and Robson SC: CD39 and control of cellular immune
responses. Purinergic Signal. 3:171–180. 2007.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Schmetterer KG, Neunkirchner A and Pickl
WF: Naturally occurring regulatory T cells: Markers, mechanisms,
and manipulation. FASEB J. 26:2253–2276. 2012.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Seddiki N, Santner-Nanan B, Martinson J,
Zaunders J, Sasson S, Landay A, Solomon M, Selby W, Alexander SI,
Nanan R, et al: Expression of interleukin (IL)-2 and IL-7 receptors
discriminates between human regulatory and activated T cells. J Exp
Med. 203:1693–1700. 2006.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Whiteside TL: Regulatory T cell subsets in
human cancer: Are they regulating for or against tumor progression?
Cancer Immunol Immunother. 63:67–72. 2014.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Giese M, Turiello N, Molenda N, Palesch D,
Meid A, Schroeder R, Basilico P, Benarafa C, Halatsch ME, Zimecki
M, et al: Exogenous cathepsin G upregulates cell surface MHC class
I molecules on immune and glioblastoma cells. Oncotarget.
7:74602–74611. 2016.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Tan GJ, Peng ZK, Lu JP and Tang FQ:
Cathepsins mediate tumor metastasis. World J Biol Chem. 4:91–101.
2013.PubMed/NCBI View Article : Google Scholar
|
